GLYHART 10MG TABLET

DAFAGLIFOZIN 

GLYHART® is a sodium-glucose co-transporter 2 (SGLT2) inhibitor and is primarily indicated for the improvement of blood glucose levels in adults with Type 2 Diabetes Mellitus. Clinical guidelines recommend the use of Dapagliflozin to reduce the risk for chronic kidney disease (CKD), cardiovascular (CV) death, hospitalization, and urgent heart failure (HF) visits in adults with HF among patients with Type 2 Diabetes Mellitus.